Phototherapy device and method for controlling phototherapy device

Through the phototherapy instrument and control method in the range of 590 nanometers to 850 nanometers and 1072 nanometers, the problem that existing phototherapy instruments are difficult to whiten and anti-wrinkle at the same time is solved, and the comprehensive improvement effect of the skin is achieved.

WO2025213609A1PCT designated stage Publication Date: 2025-10-16NINGBO YIMEI NIKKO-SEIKI MANUFACTURE CO LTD
View PDF 4 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/105656
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2024-04-12
Filing Date
2024-07-16
Publication Date
2025-10-16

AI Technical Summary

Technical Problem

Existing phototherapy devices are difficult to achieve both whitening and anti-wrinkle effects simultaneously. Blue light promotes the growth of melanin in the epidermis, while red light has difficulty penetrating the epidermis into the dermis.

Method used

Using phototherapy equipment in the range of 590nm-850nm and 1072nm, combined with the distribution and control method of the light-emitting units, the irradiation intensity and time are adjusted according to skin parameters to achieve whitening and anti-wrinkle effects.

Benefits of technology

Through light therapy instruments with different wavelengths and control methods, both whitening and anti-wrinkle effects are achieved, improving skin whiteness and improving wrinkles.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024105656_16102025_PF_FP_ABST
    Figure CN2024105656_16102025_PF_FP_ABST
Patent Text Reader

Abstract

Provided is a phototherapy device and a method for controlling a phototherapy device. The phototherapy device comprises: a body structure (100) and a plurality of light-emitting units (200) arranged on the body structure (100). The light-emitting unit (200) can emit at least one of the following lights: a light having a first wavelength range of 590 nanometers to 850 nanometers and a light having a second wavelength range of 1072 ± 15 nanometers. The light emitted by the light-emitting unit (200) can act on a skin area of a user.
Need to check novelty before this filing date? Find Prior Art

Description

Light therapy instrument and control method of light therapy instrument

[0001] The present application claims priority to the Chinese patent application No. 202410441104.X, filed on April 12, 2024, with the Chinese Patent Office, the content of which is incorporated herein by reference in its entirety. TECHNICAL FIELD

[0002] The present application relates to the technical field of cosmetic instruments, for example to a light therapy instrument and a control method of the light therapy instrument. BACKGROUND

[0003] Currently, different wavelengths of light have different light therapy effects on the human body. For example, inhibiting bacteria, promoting or inhibiting melanin regeneration, promoting collagen regeneration, etc. In recent years, light therapy cosmetic instruments based on different wavelengths have also been increasingly concerned by people. Light therapy generally refers to physical treatment using ultraviolet rays, infrared rays, visible light, laser, etc.

[0004] Referring to the skin tissue structure in the related art, the skin tissue is generally composed of an epidermis layer, a dermis layer and a subcutaneous tissue, and the epidermis layer has a basal layer, and melanin exists in the basal layer. When the melanin in the basal layer is more, the skin is dull and has no luster, and when the melanin in the basal layer is less, the skin is relatively fair. In addition, the deposition of local melanin will form spots such as color spots. In addition, the dermis layer contains collagen, and when the collagen in the dermis layer is lost more, the skin will produce wrinkles.

[0005] In the related art, although the skin can be irradiated by blue light 420 nanometers (nm) to achieve the effect of inhibiting bacteria, the blue light has the effect of promoting the growth of melanin in the epidermis layer, which is easy to cause the skin to become darker. Although the skin can be irradiated by red light 580 nm to reach the epidermis layer of the skin to inhibit the production of melanin, thereby achieving the effect of whitening, the light of this wavelength is easily absorbed by melanin and water in the epidermis layer and cannot penetrate the epidermis layer to enter the dermis layer, thereby achieving the effect of anti-wrinkles.

[0006] SUMMARY

[0007] The present application provides a light therapy instrument and a control method of the light therapy instrument, which can take into account the effects of whitening and anti-wrinkles.

[0008] In one aspect, an embodiment of the present application provides a light therapy instrument, comprising: a main body structure and a plurality of light emitting units arranged on the main body structure.

[0009] The light emitting units can emit light of at least one of the following: light in a first wavelength range of 590 nanometers-850 nanometers and light in a second wavelength range of 1072±15 nanometers; the light emitted by the light emitting units can act on a skin area of a user.

[0010] In some embodiments, when the light emitting unit is capable of emitting light in the second wavelength range, the light emitted by the light emitting unit is one of 1064 nm, 1065 nm, 1067 nm, 1070 nm, 1071 nm, 1072 nm, 1073 nm, or 1074 nm.

[0011] In some embodiments, when the light emitting unit is capable of emitting light in the first wavelength range, the light emitted by the light emitting unit is in at least one of the ranges of 590 nm - 620 nm, 620 nm - 640 nm, 650 nm - 670 nm, 740 nm - 760 nm, or 820 nm - 860 nm.

[0012] In some embodiments, when the light emitting unit is capable of emitting light in the 590 nm - 620 nm wavelength range, the light emitted by the light emitting unit is one of 606 nm, 610 nm, or 616 nm.

[0013] In some embodiments, when the light emitting unit is capable of emitting light in the 620 nm - 640 nm wavelength range, the light emitted by the light emitting unit is one of 624 nm, 630 nm, or 633 nm.

[0014] In some embodiments, when the light emitting unit is capable of emitting light in the 650 nm - 670 nm wavelength range, the light emitted by the light emitting unit is one of 660 nm or 668 nm.

[0015] In some embodiments, when the light emitting unit is capable of emitting light in the 740 nm - 760 nm wavelength range, the light emitted by the light emitting unit is 751 nm.

[0016] In some embodiments, when the light emitting unit is capable of emitting light in the 820 nm - 860 nm wavelength range, the light emitted by the light emitting unit is one of 830 nm, 831 nm, 846 nm, or 850 nm.

[0017] In some embodiments, the light emitting unit is capable of simultaneously emitting light at one of 610 nm, 630 nm, or 660 nm in the first wavelength range, and light in the second wavelength range.

[0018] In some embodiments, the light emitting unit is capable of simultaneously emitting light at one of 610 nm, 630 nm, or 660 nm in the first wavelength range, light at one of 830 nm or 850 nm in the first wavelength range, and light in the second wavelength range.

[0019] In some embodiments, the light emitting units are capable of simultaneously emitting light of one of 830 nm or 850 nm, and five of 610 nm, 630 nm, 660 nm, and 1072 nm.

[0020] In some embodiments, the plurality of light emitting units are uniformly distributed on the main body structure, and each light emitting unit is capable of simultaneously emitting light of a first wavelength range and a second wavelength range.

[0021] In some embodiments, the plurality of light emitting units are uniformly distributed on the main body structure, the main body structure comprises a first region and a second region; the light emitting units capable of emitting light in the second wavelength range are arranged in the first region, wherein the degree of wrinkles on the skin of a user corresponding to the first region is greater than the degree of wrinkles on the skin of a user corresponding to the second region.

[0022] In some embodiments, the plurality of light emitting units are uniformly distributed on the main body structure, the main body structure comprises a third region and a fourth region; the light emitting units capable of emitting light in the first wavelength range are arranged in the third region; wherein the third region and the fourth region have a corresponding relationship of at least one of: the degree of whitening on the skin of a user corresponding to the third region is lower than the degree of whitening on the skin of a user corresponding to the fourth region, and the degree of spots on the skin of a user corresponding to the third region is higher than the degree of spots on the skin of a user corresponding to the fourth region.

[0023] In some embodiments, the main body structure is one of a facial phototherapy structure, a hand phototherapy structure, a neck phototherapy structure, an eye phototherapy structure, or a lip phototherapy structure.

[0024] In some embodiments, the light emitting unit is one of a light emitting diode (LED) chip, a mini light emitting diode (mini-LED), a micro light emitting diode (micro-LED), or a laser light emitting part.

[0025] Another aspect of the present application provides a control method of a phototherapy instrument, the control device of the phototherapy instrument comprises the phototherapy instrument according to any one of the embodiments of the present application, further comprising a collection sensor and a controller, the control method comprising:

[0026] controlling the collection sensor to collect a wrinkle parameter of a current skin area;

[0027] obtaining a wrinkle degree of the current skin area according to the wrinkle parameter;

[0028] adjusting at least one parameter of the number of turned-on light emitting units, the irradiation intensity, or the irradiation time of the region of the phototherapy instrument corresponding to the current skin area according to the wrinkle degree.

[0029] In some embodiments, the adjusting at least one parameter of the number of turned-on light-emitting units, the irradiation intensity, or the irradiation time of the light-emitting units in the region of the light-therapy instrument corresponding to the current skin region according to the wrinkle degree comprises:

[0030] The number of light-emitting units capable of emitting the second wavelength range is positively correlated with the wrinkle degree;

[0031] The irradiation intensity of the light-emitting units capable of emitting the second wavelength range is positively correlated with the wrinkle degree;

[0032] The irradiation time of the light-emitting units capable of emitting the second wavelength range is positively correlated with the wrinkle degree.

[0033] Another aspect of the present application provides a control method of a light-therapy instrument, the control device of the light-therapy instrument comprising the light-therapy instrument according to any one of the embodiments of the present application, further comprising a collection sensor and a controller, and the control method comprising:

[0034] controlling the collection sensor to collect a whiteness parameter of a current skin region;

[0035] obtaining a whitening degree of the current skin region according to the whiteness parameter;

[0036] adjusting at least one parameter of the number of turned-on light-emitting units, the irradiation intensity, or the irradiation time of the light-emitting units in the region of the light-therapy instrument corresponding to the current skin region according to the whitening degree.

[0037] In some embodiments, the adjusting at least one parameter of the number of turned-on light-emitting units, the irradiation intensity, or the irradiation time of the light-emitting units in the region of the light-therapy instrument corresponding to the current skin region according to the whitening degree comprises:

[0038] The number of light-emitting units capable of emitting the first wavelength range is negatively correlated with the whitening degree;

[0039] The irradiation intensity of the light-emitting units capable of emitting the first wavelength range is negatively correlated with the whitening degree;

[0040] The irradiation time of the light-emitting units capable of emitting the first wavelength range is negatively correlated with the whitening degree.

[0041] Another aspect of the present application provides a control method of a light-therapy instrument, the control device of the light-therapy instrument comprising the light-therapy instrument according to any one of the embodiments of the present application, further comprising a controller, and the control method comprising:

[0042] receiving a control instruction of a user;

[0043] Control the light-emitting units in the light therapy instrument to be opened simultaneously according to the control instruction; wherein, the running state includes three modes of low, middle and high;

[0044] Wherein, the running state of the light-emitting units includes at least one of the following:

[0045] The irradiation intensity of the light-emitting units in the middle mode is greater than that in the low mode, and less than that in the high mode;

[0046] The irradiation time of the light-emitting units in the middle mode is greater than that in the low mode, and less than that in the high mode;

[0047] The number of the light-emitting units in the middle mode is greater than that in the low mode, and less than that in the high mode. BRIEF DESCRIPTION OF DRAWINGS

[0048] The drawings needed to be used in the following embodiment description will be introduced as follows, the drawings in the following description are some embodiments of the present application, and other drawings can be obtained by those drawings without creative labor for those skilled in the art.

[0049] Fig. 1 is a structural schematic diagram of the light therapy instrument according to an embodiment of the present application;

[0050] Fig. 2 is a diagram showing the relationship between the wavelength of the LED chip emitted by the light therapy instrument and the absorption coefficient according to an embodiment of the present application;

[0051] Fig. 3 is a diagram showing the relationship between the wavelength of the LED chip emitted by the light therapy instrument and the water transmittance according to an embodiment of the present application;

[0052] Fig. 4 is a structural schematic diagram of the main body structure of the light therapy instrument according to an embodiment of the present application;

[0053] Fig. 5 is an exploded view of the main body structure of the light therapy instrument according to an embodiment of the present application;

[0054] Fig. 6 is a structural schematic diagram of the main body structure of the light therapy instrument according to another embodiment of the present application;

[0055] Fig. 7 is an exploded view of the main body structure of the light therapy instrument according to another embodiment of the present application;

[0056] Fig. 8 is a flow chart of the control method of the light therapy instrument according to an embodiment of the present application;

[0057] FIG. 9 is a flow chart of a control method of a light therapy instrument according to an embodiment of the present application;

[0058] FIG. 10 is a flow chart of a control method of a light therapy instrument according to another embodiment of the present application;

[0059] FIG. 11 is a diagram of skin wrinkle image collection of subjects No. 01 and No. 23 using a Primos-CR tester according to an embodiment of the present application. DETAILED DESCRIPTION

[0060] The embodiments of the present application will be described below with reference to the accompanying drawings. The embodiments described are some of the embodiments of the present application. Based on the embodiments of the present application, all other embodiments obtained by those of ordinary skill in the art without creative effort should fall within the scope of the present application.

[0061] The terms "first", "second", and the like in the description and the claims of the present application and the above-described drawings are used to distinguish similar objects, and do not necessarily indicate a specific order or sequence. It should be understood that the data thus used can be interchanged under appropriate circumstances, so that the embodiments of the present application described herein can be implemented in other than the order illustrated or described herein. In addition, the terms "include" and "have" and any variations thereof are intended to cover non-exclusive inclusion.

[0062] FIG. 1 is a structural schematic diagram of a light therapy instrument according to an embodiment of the present application. As shown in FIG. 1, the light therapy instrument includes a main body structure 100 and a plurality of light emitting units 200 arranged on the main body structure 100.

[0063] The light emitting units 200 can emit light of at least one of a first wavelength range of 590 nm-850 nm and a second wavelength range of 1072±15 nm. The light emitted by the light emitting units 200 can act on a skin area of a user.

[0064] The main body structure 100 can be a frame structure of the light therapy instrument except the light emitting unit 200, such as a mask-like main body structure of a facial light therapy instrument, or a hand-like main body structure of a hand light therapy instrument. The light emitting unit 200 is arranged on the main body structure 100, and can emit light under the control of the related controller. The light emitting unit 200 can be one of a light emitting diode (LED) chip, a mini light emitting diode (mini-LED), or a micro light emitting diode (micro-LED), or a laser light emitting part, and the light emitting unit 200 capable of emitting light in the above-mentioned wavelength range and wavelength value is within the protection scope of the present application. When the light emitting unit 200 is an LED chip, a shell 300 encapsulating the light emitting unit 200 can also be arranged on the main body structure 100, and the LED chip can be a single-color LED or a multi-color LED. The shell 300 can guide the light emitted by the light emitting unit 200, and the inner wall of the shell 300 can be provided with a reflective film to reflect the light emitted by the light emitting unit 200, for example. When a user uses it, the side surface of the main body structure 100 on which the light emitting unit 200 is arranged faces the user's skin, the light emitting unit 200 emits light under the control of the controller, and the shell 300 guides the light to the user's skin to act on the skin.

[0065] It should be noted that the light emitting unit 200 can emit light in the first wavelength range or the second wavelength range, or the light emitting unit 200 can emit light in the first wavelength range and the second wavelength range, wherein the first wavelength range is 590-850 nm, and the second wavelength range is 1072±15 nm. When the light emitting unit 200 can emit light of multiple wavelengths, and the LED chip is a single-color LED, the light emitting unit 200 can include multiple LED chips. Alternatively, multiple mini-LEDs or multiple micro-LEDs or multiple laser light emitting parts can also be included to emit light of multiple wavelengths.

[0066] Fig. 2 is a diagram showing the relationship between the wavelength of the light emitted by the light emitting unit of the light therapy instrument and the absorption coefficient, and Fig. 3 is a diagram showing the relationship between the wavelength of the light emitted by the light emitting unit of the light therapy instrument and the water transmittance. As shown in Figs. 2 and 3, the light in the first wavelength range of 590-850 nm belongs to the near-infrared band range. The light in this band range can promote cell proliferation based on the cytochrome c oxidase excitation principle. Moreover, the longer the wavelength of the light in this band range, the less the melanin and hemoglobin absorb the light. The shorter the wavelength of the light in this band range, the more the melanin and hemoglobin absorb the light. In addition, for the first wavelength range, the longer the wavelength, the higher the water transmittance of the light in this band range, and the shorter the wavelength, the lower the water transmittance of the light in this band range. Thus, the light in the first wavelength range can basically reach the epidermis of the user. Moreover, the light with a shorter wavelength, such as light close to 590 nm, can be absorbed by water and cannot reach the dermis, and the light with a longer wavelength, such as light close to 850 nm, can be transmitted by water and reach the dermis. Thus, the closer the wavelength of the light in this band range to 590 nm, the higher the absorption coefficient of the melanin for the light in this band range, the more the light acts on the melanin, the more the production of melanin is inhibited, the better the whitening effect, and the closer the wavelength to 850 nm, the lower the absorption coefficient of the melanin for the light in this band range, the more the light is transmitted, and finally the light can act on the dermis to stimulate the regeneration of collagen in the dermis and achieve a certain anti-wrinkle effect.

[0067] The light in the second wavelength range of 1072±15 nm (i.e., 1057-1087 nm) belongs to the infrared band range. The light in this band range can stimulate the regeneration of collagen in the dermis based on the principle of regulating capsaicin channels. Since the melanin, hemoglobin, and water have high transmittance for the light with a wavelength of 1057-1087 nm (as shown in Fig. 3, the water transmittance is about 93%), the light in this band range can pass through the melanin and hemoglobin in the epidermis and reach the dermis without being absorbed by the water in the dermis, thereby stimulating the regeneration of collagen in the dermis and achieving an anti-wrinkle effect. Thus, when the light emitting unit 200 emits light in the first wavelength range, it mainly acts on the boundary between the epidermis and the dermis, and the whitening effect is dominant, and the anti-wrinkle effect is auxiliary. When the light emitting unit 200 emits light in the second wavelength range, it mainly acts on the dermis, and the anti-wrinkle effect is dominant, and the whitening effect is auxiliary. When the light emitting unit 200 emits light in both the first wavelength range and the second wavelength range, since both belong to the infrared band range, they are based on the principle of inhibiting melanin and stimulating the regeneration of collagen, and the light in the two bands will not have opposite and canceling effects, but will have a superimposed effect, acting on the epidermis and the dermis at the same time, so that the whitening and anti-wrinkle effects are both optimal.

[0068] In some embodiments, when the light emitting unit is capable of emitting light in the second wavelength range, the wavelength of the light emitted by the light emitting unit 200 is one of 1064 nm, 1065 nm, 1067 nm, 1070 nm, 1071 nm, 1072 nm, 1073 nm, or 1074 nm.

[0069] As can be seen from FIG. 3, when the wavelength of the light emitted by the light emitting unit 200 is any one of 1064 nm, 1065 nm, 1067 nm, 1070 nm, 1071 nm, 1072 nm, 1073 nm, or 1074 nm, the transmittance of water is at or near the peak. When the wavelength of the light emitted by the light emitting unit 200 is 1072 nm, the transmittance of water is at the peak. As a result of the effect on the dermis layer, the best wrinkle removal effect can be achieved.

[0070] In some embodiments, when the light emitting unit 200 is capable of emitting light in the first wavelength range, the wavelength of the light emitted by the light emitting unit 200 is in at least one of the ranges of 590 nm-620 nm, 620 nm-640 nm, 650 nm-670 nm, 740 nm-760 nm, or 820 nm-860 nm.

[0071] When deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) in cells is stimulated, the peaks appear in these wave bands, and thus, setting the light emitting unit 200 to emit light in the corresponding wave band can better stimulate cells and achieve better results.

[0072] In some embodiments, when the light emitting unit 200 is capable of emitting light in the 590 nm-620 nm wavelength range, the wavelength of the light emitted by the light emitting unit 200 is one of 606 nm, 610 nm, or 616 nm.

[0073] When the wavelength of the light emitted by the light emitting unit 200 is 606 nm, a peak appears when DNA in cells is stimulated, and when the wavelength of the light emitted by the light emitting unit 200 is 616 nm, a peak appears when RNA in cells is stimulated. When the wavelength of the light emitted by the light emitting unit 200 is 610 nm, the working condition of the existing LED lamp can be met, the light emitting unit 200 is easy to prepare, and the wavelength is between 606 nm and 616 nm, which can take into account the effects achieved by 606 nm and 616 nm.

[0074] In some embodiments, when the light emitting unit 200 is capable of emitting light in the 620 nm-640 nm wavelength range, the wavelength of the light emitted by the light emitting unit 200 is one of 624 nm, 630 nm, or 633 nm.

[0075] When the wavelength of the light emitted by the light-emitting unit 200 is at 624 nm, a peak appears when stimulating cell DNA, and when the wavelength of the light emitted by the light-emitting unit 200 is at 633 nm, a peak appears when stimulating cell DNA. When the wavelength of the light emitted by the light-emitting unit 200 is at 630 nm, the working condition of the existing LED lamp can be met, the light-emitting unit 200 is easy to prepare, and the wavelength is between 624 nm and 633 nm, which can take into account the effects that can be achieved at 624 nm and 633 nm.

[0076] In some embodiments, when the light-emitting unit 200 can emit light in the wavelength range of 650 nm-670 nm, the wavelength of the light emitted by the light-emitting unit 200 is 660 nm or 668 nm.

[0077] When the wavelength of the light emitted by the light-emitting unit 200 is at 668 nm, a peak appears when stimulating cell RNA. When the wavelength of the light emitted by the light-emitting unit 200 is at 660 nm, the working condition of the existing LED lamp can be met, the light-emitting unit 200 is easy to prepare, and the wavelength is near 668 nm, which can take into account the effects that can be achieved at 668 nm.

[0078] In some embodiments, when the light-emitting unit 200 can emit light in the wavelength range of 740 nm-760 nm, the wavelength of the light emitted by the light-emitting unit 200 is 751 nm.

[0079] When the wavelength of the light emitted by the light-emitting unit 200 is at 751 nm, a peak appears when stimulating cell DNA.

[0080] In some embodiments, when the light-emitting unit 200 can emit light in the wavelength range of 820 nm-860 nm, the wavelength of the light emitted by the light-emitting unit 200 is one of 830 nm, 831 nm, 846 nm, or 850 nm.

[0081] When the wavelength of the light emitted by the light-emitting unit 200 is at 831 nm, a peak appears when stimulating cell DNA, and when the wavelength of the light emitted by the light-emitting unit 200 is at 846 nm, a peak appears when stimulating cell DNA. When the wavelength of the light emitted by the light-emitting unit 200 is at 830 nm, the working condition of the existing LED lamp can be met, the light-emitting unit 200 is easy to prepare, and the wavelength is near 831 nm, which can take into account the effects that can be achieved at 831 nm. When the wavelength of the light emitted by the light-emitting unit 200 is at 850 nm, the working condition of the existing LED lamp can be met, the light-emitting unit 200 is easy to prepare, and the wavelength is near 846 nm, which can take into account the effects that can be achieved at 846 nm.

[0082] In some embodiments, the light emitting unit 200 can simultaneously emit light of one of 610 nm, 630 nm or 660 nm in the first wavelength range, and light in the second wavelength range. In some embodiments, the light in the second wavelength range can have a wavelength of 1072 nm.

[0083] When the light emitting unit 200 simultaneously emits light of 610 nm and light in the second wavelength range, both the stimulation effect on cell RNA and DNA and the anti-wrinkle effect of the second wavelength range can be achieved; when the light emitting unit 200 simultaneously emits light of 630 nm and light in the second wavelength range, both the stimulation effect on cell DNA and the anti-wrinkle effect of the second wavelength range can be achieved; when the light emitting unit 200 simultaneously emits light of 660 nm and light in the second wavelength range, both the stimulation effect on cell RNA and the anti-wrinkle effect of the second wavelength range can be achieved; and thus, whitening and anti-wrinkle can be simultaneously performed.

[0084] It should be noted that, since the light of one of 610 nm, 630 nm or 660 nm belongs to the visible light band, the user can visually perceive the emission of light when using the light therapy device.

[0085] In some embodiments, the combination of light emitted by the light emitting unit 200 in this embodiment can be one of 610 nm+1072 nm, 630 nm+1072 nm or 660 nm+1072 nm.

[0086] In some embodiments, the light emitting unit 200 can simultaneously emit light of one of 610 nm, 630 nm or 660 nm in the first wavelength range, light of at least one of 830 nm or 850 nm in the first wavelength range, and light in the second wavelength range. In some embodiments, the light in the second wavelength range can have a wavelength of 1072 nm.

[0087] In some embodiments, the light emitting unit 200 can simultaneously emit light of one of 610 nm, 630 nm or 660 nm in the first wavelength range, light of one of 830 nm or 850 nm in the first wavelength range, and light in the second wavelength range. In some embodiments, the light in the second wavelength range can have a wavelength of 1072 nm.

[0088] On the basis of the previous embodiment, i.e., under the premise of taking into account the stimulation effect on cell DNA and / or RAN and the anti-wrinkle effect, the addition of light of one of 830 nm or 850 nm in the first wavelength range can accelerate the growth of new cells, thereby improving the whitening and anti-wrinkle effects.

[0089] In some embodiments, the combination of light emitted by the light emitting unit 200 in this embodiment can be one of 610nm+830nm+1072nm, 630nm+830nm+1072nm, 660nm+830nm+1072nm, 610nm+850nm+1072nm, 630nm+850nm+1072nm, or 660nm+850nm+1072nm.

[0090] In other embodiments, the light in the first wavelength range can also be other point values in addition to the above point values, and the light in the second wavelength range can also be other point values in addition to the above point values.

[0091] In some embodiments, the light emitting unit 200 can simultaneously emit light of two wavelengths of 610nm, 630nm or 660nm in the first wavelength range, light of one wavelength of 830nm or 850nm in the first wavelength range, and light in the second wavelength range. The wavelength of the light in the second wavelength range can be 1072nm.

[0092] On the basis of the above embodiment, two wavelengths of 610nm, 630nm or 660nm are selected, that is, on the premise of being able to take into account the stimulating effect on cell DNA and / or RAN, the wrinkle-removing effect, and the effect of accelerating the growth of new cells, the breadth of stimulating cell RNA and / or DNA can also be widened, that is, the stimulation of RNA and / or DNA of multiple cells can reach a peak, thereby improving the whitening and wrinkle-removing effects.

[0093] In some embodiments, the combination of light emitted by the light emitting unit 200 in this embodiment can be one of 610nm+660nm+830nm+1072nm, 630nm+660nm+830nm+1072nm, 610nm+630nm+830nm+1072nm, 610nm+660nm+850nm+1072nm, 630nm+660nm+850nm+1072nm, 610nm+630nm+850nm+1072nm.

[0094] In other embodiments, the light in the first wavelength range can also be other point values in addition to the above point values, and the light in the second wavelength range can also be other point values in addition to the above point values.

[0095] In some embodiments, the light emitting unit 200 can simultaneously emit light of three wavelengths of 610nm, 630nm and 660nm in the first wavelength range, light of one wavelength of 830nm or 850nm in the first wavelength range, and light in the second wavelength range. In some embodiments, the wavelength of the light in the second wavelength range can be 1072nm.

[0096] On the basis of the previous embodiment, three wavelengths of light are selected from 610 nm, 630 nm and 660 nm, that is, on the premise of being able to take into account the stimulating effect on cell DNA and / or RAN, the effect of wrinkle removal effect and the effect of accelerating the growth of new cells, it is also possible to further broaden the scope of stimulating cell RNA and / or DNA, that is, the stimulation of the RNA and / or DNA of a variety of cells can reach a peak, thereby improving the whitening and wrinkle removal effect.

[0097] In some embodiments, the combination of light emitted by the light emitting unit 200 in this embodiment can be one of 610 nm+630 nm+660 nm+830 nm+1072 nm, or 610 nm+630 nm+660 nm+850 nm+1072 nm. Among them, the light in the first wavelength range can also be other point values in addition to the above point values, and the light in the second wavelength range can also be other point values in addition to the above point values.

[0098] In some embodiments, the light emitting unit 200 can emit one of 830 nm or 850 nm, and five wavelengths of light of 610 nm, 630 nm, 660 nm and 1072 nm. Better whitening and wrinkle removal effects can be achieved.

[0099] In some embodiments, a plurality of light emitting units 200 are uniformly distributed on the main body structure 100, and each light emitting unit 200 can simultaneously emit light in the first wavelength range and the second wavelength range.

[0100] It can be understood that a plurality of light emitting units 200 are distributed on the main body structure 100, and each light emitting unit 200 can simultaneously emit light in two wavelength ranges, so that the skin range covered by the main body structure 100 can simultaneously achieve the effects of whitening and wrinkle removal.

[0101] Exemplarily, each light emitting unit 200 can emit light of one combination of 610nm+1072nm, 630nm+1072nm, 660nm+1072nm, 610nm+830nm+1072nm, 630nm+830nm+1072nm, 660nm+830nm+1072nm, 610nm+850nm+1072nm, 630nm+850nm+1072nm, 660nm+850nm+1072nm, 610nm+660nm+830nm+1072nm, 630nm+660nm+830nm+1072nm, 610nm+630nm+830nm+1072nm, 610nm+660nm+850nm+1072nm, 630nm+660nm+850nm+1072nm, 610nm+630nm+850nm+1072nm, 610nm+630nm+660nm+830nm+1072nm, or 610nm+630nm+660nm+850nm+1072nm. Among them, the light in the first wavelength range can also be other point values in addition to the above point values, and the light in the second wavelength range can also be other point values in addition to the above point values.

[0102] In some embodiments, the plurality of light emitting units 200 are uniformly distributed on the main body structure 100, the main body structure 100 comprises a first area and a second area; the light emitting unit 200 capable of emitting light in the second wavelength range is arranged in the first area, wherein the degree of wrinkles on the skin of the user corresponding to the first area is greater than the degree of wrinkles on the skin of the user corresponding to the second area.

[0103] In some embodiments, the regions on the main structure 100 corresponding to regions where the user's skin has more wrinkles (such as the corners of the eyes, the corners of the mouth, etc.) can be arranged with more rows of light emitting units 200 capable of emitting light in the second wavelength range. In one embodiment, after arranging a plurality of light emitting units 200 capable of emitting light in the first wavelength range and the second wavelength range simultaneously on the main structure 100 uniformly, the regions such as the corners of the eyes, the corners of the mouth, etc. can be increased in density of light emitting units 200 capable of emitting light in the second wavelength range by adding light emitting units 200 capable of emitting light in the second wavelength range only. In another embodiment, in order to save costs, light emitting units 200 capable of emitting light in the first wavelength range and the second wavelength range simultaneously can be arranged only in regions with more wrinkles, and light emitting units 200 capable of emitting light in the first wavelength range only can be arranged in other regions. Among them, the light emitting units 200 capable of emitting light in the first wavelength range and the second wavelength range simultaneously are arranged, and the wavelength combination can be one of 610nm+1072nm, 630nm+1072nm, 660nm+1072nm, 610nm+830nm+1072nm, 630nm+830nm+1072nm, 660nm+830nm+1072nm, 610nm+850nm+1072nm, 630nm+850nm+1072nm, 660nm+850nm+1072nm, 610nm+660nm+830nm+1072nm, 630nm+660nm+830nm+1072nm, 610nm+630nm+830nm+1072nm, 610nm+660nm+850nm+1072nm, 630nm+660nm+850nm+1072nm, 610nm+630nm+850nm+1072nm, 610nm+630nm+660nm+830nm+1072nm or 610nm+630nm+660nm+850nm+1072nm. Among them, the light in the first wavelength range can also be other point values in addition to the above point values, and the light in the second wavelength range can also be other point values in addition to the above point values.

[0104] The light-emitting unit 200 emitting light in a single first wavelength range, and the wavelength combination can be one of 610 nm, 630 nm, 660 nm, 610 nm+830 nm, 630 nm+830 nm, 660 nm+830 nm, 610 nm+850 nm, 630 nm+850 nm, 660 nm+850 nm, 610 nm+660 nm+830 nm, 630 nm+660 nm+830 nm, 610 nm+630 nm+830 nm, 610 nm+660 nm+850 nm, 630 nm+660 nm+850 nm, 610 nm+630 nm+850 nm, 610 nm+630 nm+660 nm+830 nm, or 610 nm+630 nm+660 nm+850 nm. The selection can be made according to actual conditions. Among them, the light in the first wavelength range can also be other point values in addition to the above point values, and the light in the second wavelength range can also be other point values in addition to the above point values.

[0105] It should be noted that the degree of wrinkles can be evaluated by a wrinkle parameter, such as by an image collector to capture a skin area image and perform corresponding analysis, the deeper the wrinkle depth and / or the more the number of wrinkles, the more wrinkles are likely to be.

[0106] In some embodiments, the plurality of light-emitting units 200 are uniformly distributed on the main body structure 100, the main body structure 100 comprises a third region and a fourth region; the light-emitting unit 200 capable of emitting light in a first wavelength range is arranged in the third region; wherein the third region and the fourth region have a corresponding relationship as follows: the whitening degree of the skin of the user corresponding to the third region is lower than the whitening degree of the skin of the user corresponding to the fourth region, and the spot degree of the skin of the user corresponding to the third region is higher than the spot degree of the skin of the user corresponding to the fourth region.

[0107] Referring to the skin tissue structure in the related art, the skin tissue includes, from shallow to deep, an epidermis layer, a dermis layer, and a subcutaneous tissue, etc. In this application, the 1072±15 nm wavelength mainly hits the deep part of the dermis layer, and can remove wrinkles. If the cause of some spots of the user is in the deep part of the skin, the 1072±15 nm wavelength has a good spot lightening effect; but the wavelength of 590-850 nm can also hit the dermis layer, and the depth of the dermis layer hit by the wavelength of 590-850 nm is shallower than that hit by the wavelength of 1072±15 nm, so the wavelength of 1072±15 nm is more beneficial to removing wrinkles; in the melanin layer, the effect of the light of the wavelength of 590-850 nm is more than that of the light of the wavelength of 1072±15 nm, that is, the light of the wavelength of 590-850 nm is more beneficial to whitening and / or lightening spots.

[0108] In order to save costs, the light emitting units 200 capable of emitting the first wavelength range can be arranged in more rows in the area of the main body structure 100 corresponding to the area with more skin color spots of the user, such as the cheek. In an embodiment, after the plurality of light emitting units 200 capable of simultaneously emitting the first wavelength and the second wavelength range are uniformly arranged on the main body structure 100, the light emitting units 200 capable of emitting the first wavelength range can be added in the areas such as the cheek and forehead to increase the density of the light emitting units 200 capable of emitting the first wavelength range. In another embodiment, in order to save costs, the light emitting units 200 capable of simultaneously emitting the first wavelength range and the second wavelength range can be arranged only in the area with more wrinkles, and the light emitting units 200 capable of emitting the first wavelength range can be arranged in the areas such as the cheek and forehead in a concentrated manner, and the arrangement density of the areas such as the cheek and forehead is greater than that of other areas.

[0109] In some embodiments, the light emitting units 200 capable of simultaneously emitting the first wavelength and the second wavelength range are arranged, and the wavelength combination can be one of 610nm+1072nm, 630nm+1072nm, 660nm+1072nm, 610nm+830nm+1072nm, 630nm+830nm+1072nm, 660nm+830nm+1072nm, 610nm+850nm+1072nm, 630nm+850nm+1072nm, 660nm+850nm+1072nm, 610nm+660nm+830nm+1072nm, 630nm+660nm+830nm+1072nm, 610nm+630nm+830nm+1072nm, 610nm+660nm+850nm+1072nm, 630nm+660nm+850nm+1072nm, 610nm+630nm+850nm+1072nm, 610nm+630nm+660nm+830nm+1072nm, or 610nm+630nm+660nm+850nm+1072nm. Among them, the light in the first wavelength range can also be other point values in addition to the above point values, and the light in the second wavelength range can also be other point values in addition to the above point values.

[0110] The light-emitting unit 200 of the single-emission first wavelength range can have a wavelength combination of one of 610 nm, 630 nm, 660 nm, 610 nm+830 nm, 630 nm+830 nm, 660 nm+830 nm, 610 nm+850 nm, 630 nm+850 nm, 660 nm+850 nm, 610 nm+660 nm+830 nm, 630 nm+660 nm+830 nm, 610 nm+630 nm+830 nm, 610 nm+660 nm+850 nm, 630 nm+660 nm+850 nm, 610 nm+630 nm+850 nm, 610 nm+630 nm+660 nm+830 nm, or 610 nm+630 nm+660 nm+850 nm. The selection can be made according to actual conditions. The light in the first wavelength range can also be other point values in addition to the above point values, and the light in the second wavelength range can also be other point values in addition to the above point values.

[0111] It should be noted that the degree of spots can be evaluated by the white parameter, such as testing the skin by a skin melanin tester. The more melanin, the more spots on the skin, the higher the degree of spots, and the lower the degree of whitening. The degree of whitening can be determined by a skin color sensor, compared with the color value, to obtain the degree of whitening. The darker the color value, the darker the skin, and the lower the degree of whitening.

[0112] The "+" in the above embodiments represents combination and sum, and does not represent operation.

[0113] In some embodiments, the main body structure 100 is one of a facial light therapy structure, a hand light therapy structure, a neck light therapy structure, an eye light therapy structure, or a lip light therapy structure.

[0114] In some embodiments, the light-emitting unit combination of any embodiment of the present application can be arranged on the main body structure 100 as needed. For example, FIG. 4 is a structural schematic diagram of a main body structure of a light therapy instrument according to an embodiment of the present application. FIG. 5 is an exploded structural view of a main body structure of a light therapy instrument according to an embodiment of the present application. As shown in FIGS. 4 and 5, the main body structure 100 is a facial light therapy structure, which includes a transparent layer 010, an FPC (Flexible Printed Circuit) layer 012, and an outer cover 013 arranged in sequence from inside to outside, and the FPC layer 012 is provided with a plurality of light-emitting pieces (i.e., the light-emitting unit 200) on the side close to the transparent layer 010; a shielding layer 011 for shielding the FPC layer 012 is arranged between the transparent layer 010 and the FPC layer 012, and the shielding layer 011 is provided with a light-transmitting portion corresponding to the position of the light-emitting piece. In addition, a power line 014 is also provided.

[0115] Fig. 6 is a structural schematic diagram of a main structure of a light therapy instrument according to another embodiment of the present application. Fig. 7 is an exploded structural view of the main structure of the light therapy instrument according to another embodiment of the present application.

[0116] In the main structure 100, the hand light therapy structure includes a housing, a light-transmitting part, and an FPC layer 028, and a transparent layer 031 is snap-fitted to the housing and a receiving cavity 027 for mounting the FPC layer 028 is formed between the housing and the transparent layer 031. In addition, the hand light therapy structure further includes a light emitting member (i.e., the light emitting unit 200) disposed in the receiving cavity 027 and close to one side of the transparent layer 031, a hand supporting part disposed below the transparent layer 031 and forming a light therapy chamber 030 for the hand to extend into between the transparent layer 031 and the hand supporting part, and a shielding layer 029 disposed between the transparent layer 031 and the FPC layer 028 and provided with a light-transmitting part corresponding to the position of the light emitting member. The housing includes an upper housing 021 and a lower housing 026, and the upper housing 021 and the lower housing 026 are snap-fitted and form a control chamber 022 between the upper housing 021 and the lower housing 026. The control chamber 022 is provided with a control assembly including a control circuit board 025, a touch switch, a battery 024, and a charging interface 023. The battery 024 is electrically connected to the control circuit board 025 and the FPC layer 028. The hand light therapy structure further includes a button 020.

[0117] In other embodiments, there are neck light therapy structures, eye light therapy structures, or lip light therapy structures, etc. The core structure of the light therapy structure is the transparent layer, the FPC layer, and the shielding layer, and the light emitting unit 200 is disposed on the FPC layer. Details of each structure are not listed one by one here.

[0118] Fig. 8 is a flowchart of a control method of a light therapy instrument according to an embodiment of the present application. The control device of the light therapy instrument includes the light therapy instrument according to any embodiment of the present application, and further includes a collection sensor and a controller. As shown in Fig. 8, the control method includes the following steps:

[0119] S101, controlling the collection sensor to collect a wrinkle parameter of a current skin area;

[0120] S102, obtaining a wrinkle degree of the current skin area according to the wrinkle parameter;

[0121] S103, adjusting at least one parameter of an opening number, an irradiation intensity, or an irradiation time of a light emitting unit of a region corresponding to the current skin area on the light therapy instrument according to the wrinkle degree.

[0122] In some embodiments, the controller can be configured to store data such as the wrinkle parameter and the wrinkle degree of the current skin area.

[0123] The wrinkle degree can be evaluated by a wrinkle parameter, such as by taking an image of a skin area by an image collector (collection sensor) and performing corresponding analysis, the deeper the wrinkle depth and / or the more the number of wrinkles, the more wrinkles are likely. The light therapy instrument can obtain the wrinkle degree of the skin through the parameters collected by the collection sensor, if the wrinkle degree is large, the number of openings can be large, the irradiation intensity needs to be strong, and the irradiation time needs to be long. If the wrinkle degree is small, the number of openings can be small, the irradiation intensity needs to be weak, and the irradiation time needs to be short.

[0124] In some embodiments, adjusting at least one parameter of the number of openings, the irradiation intensity, or the irradiation time of the light-emitting units corresponding to the current skin area on the light therapy instrument according to the wrinkle degree comprises:

[0125] The number of light-emitting units capable of emitting the second wavelength range is positively correlated with the wrinkle degree;

[0126] The irradiation intensity of the light-emitting units capable of emitting the second wavelength range is positively correlated with the wrinkle degree;

[0127] The irradiation time of the light-emitting units capable of emitting the second wavelength range is positively correlated with the wrinkle degree.

[0128] When the irradiation intensity and the irradiation time of each light-emitting unit capable of emitting the second wavelength range are the same, and the adjusted parameter is the number of openings, when the wrinkle degree is less than a first wrinkle degree, control the first number of light-emitting units capable of emitting the second wavelength range to be lit; when the wrinkle degree is greater than the first wrinkle degree and less than a second wrinkle degree, control the second number of light-emitting units capable of emitting the second wavelength range to be lit; when the wrinkle degree is greater than the second wrinkle degree, control the third number of light-emitting units capable of emitting the second wavelength range to be lit; wherein the first wrinkle degree is less than the second wrinkle degree. The first number is less than the second number, and the second number is less than the third number.

[0129] When the number of openings of the light-emitting units capable of emitting the second wavelength range is all, and the irradiation time of each light-emitting unit capable of emitting the second wavelength range is the same, and the adjusted parameter is the irradiation intensity, when the wrinkle degree is less than a first wrinkle degree, control the irradiation intensity of the number of openings of the light-emitting units capable of emitting the second wavelength range to be first level; when the wrinkle degree is greater than the first wrinkle degree and less than a second wrinkle degree, control the irradiation intensity of the number of openings of the light-emitting units capable of emitting the second wavelength range to be second level; when the wrinkle degree is greater than the second wrinkle degree, control the irradiation intensity of the number of openings of the light-emitting units capable of emitting the second wavelength range to be third level; wherein the first wrinkle degree is less than the second wrinkle degree. The first level irradiation intensity is weaker than the second level, and the second level irradiation intensity is weaker than the third level.

[0130] When the number of turned-on light-emitting units capable of emitting the second wavelength range is all and the irradiation intensity of each light-emitting unit capable of emitting the second wavelength range is the same, the adjusted parameter is the irradiation time, when the wrinkle degree is less than the first wrinkle degree, the irradiation time of the number of turned-on light-emitting units capable of emitting the second wavelength range is controlled to be the first duration; when the wrinkle degree is greater than the first wrinkle degree and less than the second wrinkle degree, the irradiation time of the number of turned-on light-emitting units capable of emitting the second wavelength range is controlled to be the second duration; when the wrinkle degree is greater than the second wrinkle degree, the irradiation time of the number of turned-on light-emitting units capable of emitting the second wavelength range is controlled to be the third duration; wherein the first wrinkle degree is less than the second wrinkle degree. Wherein the first duration is less than the second duration, and the second duration is less than the third duration.

[0131] The first wrinkle degree, the second wrinkle degree, the first duration, the second duration, the third duration, the first number, the second number, the third number, the first irradiation intensity, the second irradiation intensity, and the third irradiation intensity in the above embodiments can be calibrated in advance by experiments and stored in the controller.

[0132] In this embodiment, if a single-emission first-wavelength-range light-emitting unit is arranged, the adjustment and control of the irradiation time, irradiation intensity, and turned-on number of the single-emission first-wavelength-range light-emitting unit can refer to the control method shown in FIG. 9.

[0133] FIG. 9 is a flowchart of a control method of a light therapy instrument according to an embodiment of the present application. The control device of the light therapy instrument includes the light therapy instrument according to any of the embodiments of the present application, and further includes a collection sensor and a controller. As shown in FIG. 9, the control method includes the following steps:

[0134] S201, controlling the collection sensor to collect a whiteness parameter of a current skin area;

[0135] S202, obtaining a whitening degree of the current skin area according to the whiteness parameter;

[0136] S203, adjusting at least one parameter of the turned-on number, irradiation intensity, or irradiation time of the light-emitting unit corresponding to the current skin area on the light therapy instrument according to the whitening degree.

[0137] In some embodiments, the above controller can be configured to store data such as the whiteness parameter and the whitening degree of the current skin area.

[0138] The whitening degree can be evaluated by the whiteness parameter. For example, the skin can be tested by a skin melanin tester. The more melanin, the more spots on the skin, and the lower the whitening degree. Alternatively, the whitening degree can be determined by a skin color sensor. The higher the color value, the darker the skin, and the lower the whitening degree.

[0139] The light therapy instrument can obtain the whitening degree of the skin according to the parameters collected by the collection sensor. If the whitening degree is low, the number of openings can be large, the irradiation intensity needs to be strong, and the irradiation time needs to be long. If the whitening degree is high, the number of openings can be small, the irradiation intensity needs to be weak, and the irradiation time needs to be short.

[0140] In some embodiments, adjusting at least one parameter of the number of openings, the irradiation intensity, or the irradiation time of the light-emitting unit corresponding to the current skin area on the light therapy instrument according to the whitening degree comprises:

[0141] The number of light-emitting units capable of emitting the first wavelength range is negatively correlated with the whitening degree;

[0142] The irradiation intensity of the light-emitting unit capable of emitting the first wavelength range is negatively correlated with the whitening degree;

[0143] The irradiation time of the light-emitting unit capable of emitting the first wavelength range is negatively correlated with the whitening degree.

[0144] When the irradiation intensity and the irradiation time of each light-emitting unit capable of emitting the first wavelength range are the same, and the adjusted parameter is the number of openings, when the whitening degree is less than a first whitening degree, control a fourth number of light-emitting units capable of emitting the second wavelength range to be lit; when the whitening degree is greater than the first whitening degree and less than a second whitening degree, control a fifth number of light-emitting units capable of emitting the second wavelength range to be lit; when the whitening degree is greater than the second whitening degree, control a sixth number of light-emitting units capable of emitting the second wavelength range to be lit; wherein the first whitening degree is less than the second whitening degree. The fourth number is greater than the fifth number, and the fifth number is greater than the sixth number.

[0145] When the number of openings of the light-emitting unit capable of emitting the first wavelength range is all, and the irradiation time of each light-emitting unit capable of emitting the first wavelength range is the same, and the adjusted parameter is the irradiation intensity, when the whitening degree is less than a first whitening degree, control the irradiation intensity of the number of openings of the light-emitting unit capable of emitting the second wavelength range to be four levels; when the whitening degree is greater than the first whitening degree and less than a second whitening degree, control the irradiation intensity of the number of openings of the light-emitting unit capable of emitting the second wavelength range to be five levels; when the whitening degree is greater than the second whitening degree, control the irradiation intensity of the number of openings of the light-emitting unit capable of emitting the second wavelength range to be six levels; wherein the first whitening degree is less than the second whitening degree. The four-level irradiation intensity is stronger than the five-level, and the five-level irradiation intensity is stronger than the six-level.

[0146] When the number of opened light-emitting units capable of emitting the first wavelength range is all, and the irradiation intensity of each light-emitting unit capable of emitting the first wavelength range is the same, the adjusted parameter is the irradiation time, when the whitening degree is less than the first whitening degree, the irradiation time of the number of opened light-emitting units capable of emitting the second wavelength range is controlled to be the fourth duration; when the whitening degree is greater than the first whitening degree and less than the second whitening degree, the irradiation time of the number of opened light-emitting units capable of emitting the second wavelength range is controlled to be the fifth duration; when the whitening degree is greater than the second whitening degree, the irradiation time of the number of opened light-emitting units capable of emitting the second wavelength range is controlled to be the sixth duration; wherein the first whitening degree is less than the second whitening degree. Wherein the fourth duration is greater than the fifth duration, and the fifth duration is greater than the sixth duration.

[0147] The first whitening degree, the second whitening degree, the fourth duration, the fifth duration, the sixth duration, the fourth number, the fifth number, the sixth number, the fourth irradiation intensity, the fifth irradiation intensity, and the sixth irradiation intensity in the above embodiments can be calibrated in advance by experiments and stored in the controller.

[0148] In this embodiment, if a single-emitting light-emitting unit capable of emitting the second wavelength range is arranged, the adjustment and control of the irradiation time, irradiation intensity, and number of opened light-emitting units capable of emitting the second wavelength range can refer to the control method shown in FIG. 8.

[0149] The current skin area can be an area of 3*3 centimeters (cm) or other.

[0150] FIG. 10 is a flow chart of a control method of a light therapy instrument according to another embodiment of the present application. The control device of the light therapy instrument includes the light therapy instrument according to any embodiment of the present application, and further includes a controller. As shown in FIG. 10, the control method includes the following steps:

[0151] S301, receiving a control instruction of a user;

[0152] S302, controlling the light-emitting units in the light therapy instrument to be opened simultaneously according to the control instruction; wherein the running state includes low mode, medium mode, and high mode.

[0153] The running state of the light-emitting unit includes at least one of the following:

[0154] The irradiation intensity of the light-emitting unit in the medium mode is greater than the irradiation intensity of the light-emitting unit in the low mode, and less than the irradiation intensity of the light-emitting unit in the high mode;

[0155] The irradiation time of the light-emitting unit in the medium mode is greater than the irradiation time of the light-emitting unit in the low mode, and less than the irradiation time of the light-emitting unit in the high mode;

[0156] The number of the light emitting units operating in the middle mode is greater than the number of the light emitting units operating in the low mode, and is less than the number of the light emitting units operating in the high mode.

[0157] In some embodiments, the controller may be configured to store user control instructions.

[0158] The user's control instructions include three operating modes: low, medium and high. Users can control the phototherapy equipment accordingly according to their actual needs.

[0159] In one embodiment, each light-emitting unit 200 can simultaneously emit light at five wavelengths, including one of 830 nm and 850 nm, as well as 610 nm, 630 nm, 660 nm, and 1072 nm. Furthermore, each light-emitting unit 200 can be turned on and off simultaneously, with the same irradiation intensity and duration.

[0160] The following clinical trial report is used to illustrate the effect of this embodiment.

[0161] The number of subjects was greater than 30, and the study duration was 12 consecutive weeks. The wavelength combinations of the LED chips used in the test instrument were: 605±10nm, 630±10nm, 660±10nm, 850±10nm, and 1072±15nm. The test method was to use the beauty device once daily after cleansing for 10 minutes each time.

[0162] During the experiment, facial image capture and analysis system (Visia-CR, Canfield Scientific, Inc., USA), skin fast three-dimensional imaging system (Primos-CR, Canfield Scientific, Inc., USA; used to obtain wrinkles), stratum corneum water content measuring instrument ( CM825, Courage & Khazaka, Germany; the larger the value, the higher the water content of the stratum corneum), skin melanin tester ( MX18, Courage & Khazaka, Germany; the higher the value, the higher the melanin content in the skin), skin gloss meter ( MX18, Courage & Khazaka, Germany; the larger the value, the higher the skin gloss), skin elasticity tester ( Dual MPA 580, Courage & Khazaka, Germany; the analysis parameters include R2, R7, and F4, wherein the greater the values of R2 and R7, the better the elasticity of the skin; the smaller the value of F4, the better the elasticity of the skin), a skin ultrasound diagnostic instrument (Dermascan, Cortex Technology, Denmark; the greater the thickness of the skin under normal physiological conditions, the better the state of the skin), and a handheld skin biological cell microscopic imaging system (Chuangweijing, China; the higher the skin aging index SAAID, the better the state of the skin) were used to evaluate.

[0163] In addition, a clinical evaluation of the facial skin condition of the subjects was performed by a dermatologist. The evaluation included forehead lines, glabellar lines, crow's feet, under-eye lines (right side), under-eye lines (left side), marionette lines, skin color uniformity, and pigmented spots; the evaluation criteria for glabellar lines were 0-6 points on a 7-level scale, the evaluation criteria for marionette lines were 0-7 points on an 8-level scale, the evaluation criteria for forehead lines were 0-8 points on a 9-level scale, the evaluation criteria for pigmented spots were 1-24 points on a 24-level scale, and the evaluation criteria for other indicators were 0-9 points on a 10-level scale; wherein the evaluation criteria for glabellar lines, forehead lines, and marionette lines all refer to the Skin Aging Atlas-Second Edition Asian People; the lower the score, the better the state of the skin.

[0164] The test results were statistically analyzed using statistical software SPSS Stastistics 22.0. The mean and standard deviation were calculated for the measurement data, and the Shapiro-Wilk method was used for normality test. For data meeting normality distribution, paired t-test was used for comparison before and after use of the test product, otherwise 2 related sample rank sum test was used; rank data was analyzed by 2 related sample rank sum test. The significant difference level was P<0.05.

[0165] A total of 36 qualified subjects were recruited in this trial. Among them, 2 people were lost to follow-up due to personal reasons; 1 person terminated the trial due to adverse events (Adverse Event, AE); 1 person was excluded from the statistics due to new papules in the pigmented spot area. Finally, 32 effective subjects were statistically analyzed, with an age range of 39-54 years old and an average age of 50.3±3.1 years old. The test results are summarized in Tables 1 and 2 as follows:

[0166] Table 1 Safety Results [Sum (Minimum, Median, Maximum)]

[0167] Note: Compared with the baseline value, the difference was statistically significant, *P<0.05, ***P<0.001. The lower the score, the better the skin tolerance.

[0168] Table 2 Summary of Efficacy Results

[0169] 1) Compared with the baseline value, the erythema score was significantly reduced after continuous use of the light therapy instrument for 4 weeks, 8 weeks, and 12 weeks (see Table 1); there was no significant difference in dryness, edema, and papule scores. At the same time, during the study, 1 subject had an adverse event. Therefore, it can be considered that the light therapy instrument has good clinical tolerance under the conditions of this test.

[0170] 2) Compared with the baseline value, the water content in the stratum corneum was significantly increased after continuous use for 4 weeks, 8 weeks, and 12 weeks. Therefore, it can be considered that the light therapy instrument has good moisturizing efficacy under the conditions of this test.

[0171] 3) Compared with the baseline value, the glabella wrinkle score, crow's feet wrinkle score, crow's feet wrinkle number, total volume of crow's feet wrinkle, and total area of crow's feet wrinkle were significantly reduced after use of the light therapy instrument for 4 weeks, 8 weeks, and 12 weeks; the forehead wrinkle score, under-eye wrinkle (right), under-eye wrinkle (left), and marionette line score were significantly reduced after continuous use of the light therapy instrument for 8 weeks and 12 weeks. Therefore, it can be considered that the light therapy instrument has good anti-wrinkle efficacy under the conditions of this test. (As shown in Figure 11, it can be seen that the crow's feet wrinkle of subjects No. 01 and No. 23 was significantly reduced after 12 weeks of product use relative to the baseline value).

[0172] 4) Compared with the baseline value, the Glossy parameter of skin gloss was significantly increased after continuous use of the light therapy instrument for 4 weeks, 8 weeks, and 12 weeks. Therefore, it can be considered that the light therapy instrument has certain nourishing efficacy under the conditions of this test.

[0173] 5) Compared with the baseline value, the R2 and R7 parameters were significantly increased after continuous use of the light therapy instrument for 8 weeks and 12 weeks; the F4 parameter was significantly reduced after continuous use for 12 weeks; the dermal thickness and skin aging index SAAID were significantly increased after continuous use for 12 weeks. Therefore, it can be considered that the light therapy instrument has certain firming efficacy under the conditions of this test.

[0174] 6) Compared with the baseline value, the spot score, spot area ratio, and melanin content were significantly reduced after continuous use of the light therapy instrument for 4 weeks, 8 weeks, and 12 weeks; the skin evenness score was significantly reduced after continuous use for 4 weeks, 8 weeks, and 12 weeks. Therefore, it can be considered that the light therapy instrument has certain spot-removing efficacy under the conditions of this test.

[0175] 7) Compared with the baseline value, the red area ratio of the skin was significantly reduced after continuous use of the light therapy instrument for 12 weeks. Therefore, it can be considered that the light therapy instrument has certain soothing efficacy under the conditions of this test.

[0176] In addition, the embodiments claimed in the present application, in which the light emitting unit can simultaneously emit light of the first wavelength range and the second wavelength range, can achieve the effects summarized above.

[0177] In summary, according to the light therapy instrument and the control method of the light therapy instrument provided in the embodiments of the present application, the light therapy instrument comprises: a main body structure and a plurality of light emitting units arranged on the main body structure; wherein the light emitting units can emit light comprising at least one of the following: light in a first wavelength range of 590nm-850nm and light in a second wavelength range of 1072±15nm; the light emitted by the light emitting units can act on the skin area of the user. Thus, the light therapy instrument can emit light in the 590nm-850nm wavelength range or the 1072±15nm wavelength range alone, or emit light in the 590nm-850nm wavelength range and the 1072±15nm wavelength range simultaneously. Since the light in the 1072±15nm wavelength range is longer, the energy of the light with the longer wavelength is larger, so it can penetrate melanin, blood vessels and water, and then enter the dermis layer, promote the regeneration of collagen in the dermis layer, and reduce the generation of wrinkles. Furthermore, the light in the 590nm-850nm wavelength range can be fully absorbed by the melanin at the boundary between the epidermis and the dermis layer during penetration of the epidermis, and the generation thereof is inhibited, thereby achieving the effect of whitening. Thus, when the light in the two wavelength ranges acts on the skin comprehensively, it can have a synergistic effect, can simultaneously whiten and remove wrinkles, improve the user experience, and increase the user satisfaction.

Claims

1. A phototherapy apparatus comprising: A main structure and a plurality of light-emitting units arranged on the main structure; The light emitting unit can emit at least one of the following lights: light in a first wavelength range of 590 nanometers to 850 nanometers and light in a second wavelength range of 1072±15 nanometers; the light emitted by the light emitting unit can act on the user's skin area.

2. The light therapy apparatus according to claim 1, wherein: When the light emitting unit is capable of emitting light in the second wavelength range, the wavelength of the light emitted by the light emitting unit is one of 1064 nanometers, 1065 nanometers, 1067 nanometers, 1070 nanometers, 1071 nanometers, 1072 nanometers, 1073 nanometers or 1074 nanometers.

3. The light therapy apparatus according to claim 1, wherein: When the light emitting unit is capable of emitting light in the first wavelength range, the wavelength of the light emitted by the light emitting unit is within at least one range of 590 nm-620 nm, 620 nm-640 nm, 650 nm-670 nm, 740 nm-760 nm or 820 nm-860 nm.

4. The light therapy apparatus according to claim 3, wherein: When the light emitting unit is capable of emitting light in a wavelength range of 590 nanometers to 620 nanometers, the wavelength of the light emitted by the light emitting unit is one of 606 nanometers, 610 nanometers or 616 nanometers.

5. The light therapy apparatus according to claim 3, wherein: When the light emitting unit is capable of emitting light in a wavelength range of 620 nanometers to 640 nanometers, the wavelength of the light emitted by the light emitting unit is one of 624 nanometers, 630 nanometers or 633 nanometers.

6. The light therapy apparatus according to claim 3, wherein: When the light emitting unit is capable of emitting light in a wavelength range of 650 nanometers to 670 nanometers, the wavelength of the light emitted by the light emitting unit is 660 nanometers or 668 nanometers.

7. The light therapy apparatus according to claim 3, wherein: When the light emitting unit is capable of emitting light in a wavelength range of 740 nanometers to 760 nanometers, the wavelength of the light emitted by the light emitting unit is 751 nanometers.

8. The light therapy apparatus according to claim 3, wherein: When the light emitting unit is capable of emitting light in a wavelength range of 820 nanometers to 860 nanometers, the wavelength of the light emitted by the light emitting unit is one of 830 nanometers, 831 nanometers, 846 nanometers or 850 nanometers.

9. The phototherapy apparatus according to any one of claims 1 to 3, wherein: The light emitting unit can simultaneously emit light with a wavelength of 610 nanometers, 630 nanometers, or 660 nanometers within the first wavelength range, and light within the second wavelength range.

10. The phototherapy apparatus according to any one of claims 1 to 3, wherein: The light emitting unit can simultaneously emit light of at least one wavelength of 610 nm, 630 nm or 660 nm within the first wavelength range, light of one wavelength of 830 nm or 850 nm within the first wavelength range, and light within the second wavelength range.

11. The light therapy apparatus according to claim 10, wherein: The light emitting unit can emit light of five wavelengths, namely, 830 nanometers or 850 nanometers, 610 nanometers, 630 nanometers, 660 nanometers and 1072 nanometers.

12. The light therapy apparatus according to claim 1, wherein: The plurality of light emitting units are evenly distributed on the main structure, and each light emitting unit can emit light within a first wavelength range and a second wavelength range simultaneously.

13. The light therapy apparatus according to claim 1, wherein: The multiple light-emitting units are evenly distributed on the main structure, and the main structure includes a first area and a second area; the light-emitting units capable of emitting light within a second wavelength range are arranged in the first area, wherein the degree of wrinkles on the skin of a user corresponding to the first area is greater than the degree of wrinkles on the skin of a user corresponding to the second area.

14. The light therapy apparatus according to claim 1, wherein The plurality of light-emitting units are evenly distributed on the main structure, and the main structure includes a third area and a fourth area; the light-emitting units capable of emitting light within the first wavelength range are arranged in the third area; Among them, the third area and the fourth area have at least one of the following corresponding relationships: the whitening degree of the skin of the user corresponding to the third area is lower than the whitening degree of the skin of the user corresponding to the fourth area, and the spot degree of the skin of the user corresponding to the third area is higher than the spot degree of the skin of the user corresponding to the fourth area.

15. The light therapy apparatus according to claim 1, wherein The main structure is one of a facial phototherapy structure, a hand phototherapy structure, a neck phototherapy structure, an eye phototherapy structure or a lip phototherapy structure.

16. The light therapy apparatus according to claim 1, wherein The light-emitting unit is one of a light-emitting diode (LED) chip, a sub-millimeter light-emitting diode (mini-LED), a micro light-emitting diode (micro-LED), or a laser light-emitting part.

17. A method for controlling a phototherapy apparatus, wherein the phototherapy apparatus is the phototherapy apparatus according to any one of claims 1 to 16, further comprising a data acquisition sensor and a controller, the method comprising: Controlling the acquisition sensor to acquire wrinkle parameters of the current skin area; Obtaining the wrinkle degree of the current skin area according to the wrinkle parameter; At least one parameter among the number of turned-on light-emitting units, irradiation intensity or irradiation time of the area on the phototherapy device corresponding to the current skin area is adjusted according to the wrinkle degree.

18. The control method of the phototherapy apparatus according to claim 17, wherein: The step of adjusting at least one parameter of the number of light-emitting units turned on, the irradiation intensity, or the irradiation time of the area corresponding to the current skin area on the phototherapy device according to the wrinkle degree includes: The number of light-emitting units capable of emitting light in the second wavelength range is positively correlated with the degree of wrinkles; The irradiation intensity of the light emitting unit capable of emitting light in the second wavelength range is positively correlated with the degree of wrinkles; The irradiation time of the light emitting unit capable of emitting light in the second wavelength range is positively correlated with the degree of wrinkles.

19. A method for controlling a phototherapy apparatus, wherein the phototherapy apparatus is the phototherapy apparatus according to any one of claims 1 to 16, further comprising a data acquisition sensor and a controller, the method comprising: Controlling the acquisition sensor to acquire whiteness parameters of the current skin area; Obtaining the whitening degree of the current skin area according to the whiteness parameter; At least one parameter among the number of light-emitting units turned on, the irradiation intensity or the irradiation time of the area on the phototherapy instrument corresponding to the current skin area is adjusted according to the whitening degree.

20. The control method of the phototherapy apparatus according to claim 19, wherein: The step of adjusting at least one parameter of the number of light-emitting units turned on, the irradiation intensity, or the irradiation time of the area corresponding to the current skin area on the phototherapy device according to the whitening degree includes: The number of light-emitting units capable of emitting light in the first wavelength range is negatively correlated with the degree of whitening; The irradiation intensity of the light-emitting unit capable of emitting light in the first wavelength range is negatively correlated with the whitening degree; The irradiation time of the light-emitting unit capable of emitting light in the first wavelength range is negatively correlated with the whitening degree.

21. A method for controlling a phototherapy apparatus, wherein the phototherapy apparatus is the phototherapy apparatus according to any one of claims 1 to 16, further comprising a controller, the method comprising: Receive user control instructions; According to the control instruction, the light-emitting units in the light therapy device are controlled to be turned on simultaneously and in an operating state; wherein the operating state includes three modes: a low-range mode, a mid-range mode, and a high-range mode; The operating state of the light emitting unit includes at least one of the following: The irradiance intensity of the light emitting unit when operating in the medium mode is greater than the irradiance intensity of the light emitting unit when operating in the low mode, and less than the irradiance intensity of the light emitting unit when operating in the high mode; The irradiation time when the light emitting unit is in the middle mode is longer than the irradiation time when the light emitting unit is in the low mode, and shorter than the irradiation time when the light emitting unit is in the high mode; The number of the light emitting units operating in the middle mode is greater than the number of the light emitting units operating in the low mode, and is less than the number of the light emitting units operating in the high mode.

Citation Information

Patent Citations

  • An intelligent beautifying device based on treatment area identification

    CN109865195A

  • LED phototherapy device and LED lamp

    CN111696974A

  • Beautifying and eye-nourishing mask device

    CN113101539A

  • Phototherapy instrument and control method thereof

    CN118121848A